Výsledky vyhledávání - "Mireille Fernet"

A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder

Autor: Adrian S Wagg, Sender Herschorn, Martin Carlsson, Mireille Fernet, Matthias Oelke

Publikováno v: Journal of Comparative Effectiveness Research. 11:919-925

What is this summary about? This is a summary of a study originally published in Neurourology and Urodynamics . Overactive bladder is a medical condition that causes an urgent need to urinate, which can cause accidental urination. Fesoterodine is a m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::12c71cf972570b4615dadbd27ddf1f71
https://doi.org/10.2217/cer-2022-0041

Zobrazit plný text záznamu

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine

Autor: Sender Herschorn, Martin Carlsson, Adrian Wagg, Matthias Oelke, Mireille Fernet

Publikováno v: Neurourology and Urodynamics

Aim This study describes patients with different degrees and combinations of symptom resolution in response to fesoterodine exposure to aid physicians in counselling patients with overactive bladder (OAB) on the likelihood of treatment success. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d5da81923d70dbb8ac39eb0c99b15c
https://doi.org/10.1002/nau.24706

Zobrazit plný text záznamu

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Autor: Ellen Burgess, Paula Abreu, Katharina Lins, Bruce Beckerman, John Vincent, Mireille Fernet

Publikováno v: Vascular Health and Risk Management

Mireille Fernet,1 Bruce Beckerman,2 Paula Abreu,2 Katharina Lins,3 John Vincent,2 Ellen Burgess4 1Department of Medical Affairs, Pfizer Canada Inc., Kirkland, QC, Canada; 2Department of Clinical Affairs, Pfizer Inc., New York,NY, USA; 3Department of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f981de1e6f3c5881009f4d7f66ffd977
https://doi.org/10.2147/vhrm.s170141

Zobrazit plný text záznamu

Occurrence of adverse bone events in adults and children with Gaucher disease treated with taliglucerase alfa

Autor: Michael Wajnrajch, Li-Jung Tseng, Mireille Fernet, Roy Mansfield, Betina Hernandez

Publikováno v: Molecular Genetics and Metabolism. 120:S135

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8aaabdaab4e547c70e610cecc214c55e
https://doi.org/10.1016/j.ymgme.2016.11.357

Zobrazit plný text záznamu

Evaluation of a pharmaceutical care model on diabetes management

Autor: Hariharan Diwakaran, Linda A. Jaber, Mireille Fernet, Suresh Tummalapalli, Henry Halapy

Publikováno v: The Annals of pharmacotherapy. 30(3)

OBJECTIVE: To assess the effectiveness of a pharmaceutical care model on the management of non-insulin-dependent diabetes mellitus (NIDDM) in urban African-American patients. DESIGN: Eligible patients were randomized to either a pharmacist interventi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b448522160ae0ace95bc42e59c337843
https://pubmed.ncbi.nlm.nih.gov/8833568

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání